Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5M Buy
1,018,817
+1,078
+0.1% +$28.2K 0.13% 158
2026
Q1
$28.6M Buy
+1,017,739
New +$27.1M 0.18% 103
2025
Q4
Sell
-638,374
Closed -$16.3M 1663
2025
Q3
$16.3M Buy
638,374
+205,558
+47% +$5.07M 0.16% 118
2025
Q2
$10.5M Sell
432,816
-196,319
-31% -$4.58M 0.12% 186
2025
Q1
$15.9M Sell
629,135
-248,165
-28% -$6.49M 0.23% 76
2024
Q4
$23.3M Buy
877,300
+369,044
+73% +$10M 0.34% 35
2024
Q3
$14.7M Buy
508,256
+227,349
+81% +$6.63M 0.23% 81
2024
Q2
$7.86M Buy
280,907
+22,420
+9% +$617K 0.14% 178
2024
Q1
$7.17M Sell
258,487
-254,064
-50% -$7.05M 0.13% 219
2023
Q4
$14.8M Buy
512,551
+154,988
+43% +$4.69M 0.37% 28
2023
Q3
$11.9M Buy
357,563
+112,885
+46% +$3.99M 0.35% 36
2023
Q2
$8.97M Sell
244,678
-2,910
-1% -$113K 0.32% 44
2023
Q1
$10.1M Buy
247,588
+142,184
+135% +$6.14M 0.6% 26
2022
Q4
$5.4M Buy
105,404
+77,703
+281% +$3.73M 0.35% 79
2022
Q3
$1.21M Buy
27,701
+10,338
+60% +$502K 0.12% 152
2022
Q2
$911K Buy
+17,363
New +$885K 0.12% 179

Other funds holding PFE

Empowered Funds's PFE Position: Q2 2026 in Review

Empowered Funds increased its Pfizer (PFE) stake by 0.11% in Q2 2026, buying an estimated $28.2K and bringing the position to 1,018,817 shares worth $24.5M. The position accounts for 0.13% of the portfolio, ranked #158.

Empowered Funds first reported a position in PFE in Q2 2022 and has held it in 16 quarters since. The position peaked at $28.6M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Empowered Funds held 1,018,817 shares of Pfizer worth $24.5M as of Q2 2026.
  • Empowered Funds bought 1,078 Pfizer shares in Q2 2026, an estimated $28.2K.
  • Pfizer made up 0.13% of Empowered Funds's portfolio in Q2 2026, its #158 holding.
  • Empowered Funds first reported a position in Pfizer in Q2 2022 and has held it in 16 quarters since.
  • Empowered Funds's Pfizer position peaked at $28.6M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.